Laurion Capital Management LP Graphite Bio, Inc. Transaction History

Laurion Capital Management LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$2.47 - $3.38 $1.21 Million - $1.66 Million	-490,896 Reduced 97.57%	12,204 $31,000
Q1 2023 May 15, 2023	SELL	$1.85 - $3.21 $130,425 - $226,305	-70,500 Reduced 12.29%	503,100 $1.23 Million
Q2 2022 Aug 15, 2022	BUY	$2.14 - $5.23 $1.23 Million - $3 Million	573,600 New	573,600 $1.58 Million

637K

Ticker GRPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,211,200
Description
Graphite Bio, Inc., a clinical-stage gene editing company, engages in developing therapies for serious and life-threatening diseases in the United States. It offers GPH101, a gene-edited autologous hematopoietic stem cell product candidate to directly correct the mutation that causes sickle cell disease and restore normal adult hemoglobin expres...

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Laurion Capital Management LP with notifications on news.